Sponsor · clinical trials

Population Health Research Institute clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Canada, Australia, Brazil, Germany, Spain, Italy, Netherlands, Denmark, Belgium, India, Sweden, Poland, Austria, China, Switzerland, South Korea, France, Israel, Ireland, Norway, Mexico and Turkey registers with Population Health Research Institute as lead sponsor. Synced 11 Nov 2026

26Current trials

20Recruiting now

18Drugs in these trials

22Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 11 Nov 2026 · Editorial standards

At a glance

Population Health Research Institute is the lead sponsor of 26 current clinical trials in our Canada, Australia, Brazil, Germany, Spain, Italy, Netherlands, Denmark, Belgium, India, Sweden, Poland, Austria, China, Switzerland, South Korea, France, Israel, Ireland, Norway, Mexico and Turkey registers. 20 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Apixaban, Dabigatran and Edoxaban. The most-studied condition is Atrial Fibrillation.

ClinicalTrials.gov trials by status

Recruiting2077%
Not yet open14%
Active, closed519%

Trials by phase

Not applicable1558%
Phase 3519%
Observational415%
Phase 414%
Phase 214%

Clinical trials sponsored by Population Health Research Institute

26 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk NCT04774159 · Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation Drug: Colchicine	Phase 3	Recruiting	2021-05	Germany, Netherlands, Belgium, Switzerland, Canada, Brazil, Australia
Evaluation of A Clinical Diagnostic Test for CRDS NCT06188689 · Calcium Release Deficiency Syndrome (CRDS)	Not applicable	Recruiting	2023-02	France, Belgium, Denmark, Canada, Israel
Low INR to Minimize Bleeding With Mechanical Valves Trial NCT03636295 · ClinicalTrials.gov ↗ · Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement Drug: Warfarin	Phase 3	Recruiting	2019-09	China, Germany, Spain, Italy, Netherlands, Belgium, Denmark, Canada, Brazil, South Korea
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial NCT04743765 · Hip Fractures, Myocardial Injury	Not applicable	Recruiting	2021-11	India, Spain, Italy, Netherlands, Belgium, Poland, Canada, Brazil, Mexico, Australia
International CRDS Registry NCT06508164 · ClinicalTrials.gov ↗ · Calcium Release Deficiency Syndrome	Observational	Recruiting	2024-11	France, Belgium, Denmark, Canada, Australia, Israel
Prospective Urban Rural Epidemiology Study NCT03225586 · Cardiovascular Diseases, Risk Factor, Cardiovascular, Health Behavior	Observational	Recruiting	2002-01	India, China, Sweden, Poland, Turkey, Canada, Brazil
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress NCT03968393 · Stroke, Atrial Fibrillation Drugs: Apixaban, Dabigatran, Edoxaban	Phase 4	Recruiting	2019-06	India, Germany, Spain, Italy, Netherlands, Sweden, Denmark, Switzerland, Canada, Brazil, South Korea, Australia
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction NCT04680442 · ClinicalTrials.gov ↗ · Breast Cancer, Heart Failure Drugs: Herceptin, Herzuma, Ogivri	Phase 2	Recruiting	2021-07	Canada, Brazil
Pericardiotomy in Cardiac Surgery NCT06486636 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Atrial Flutter, Cardiac Events	Not applicable	Recruiting	2024-10	Spain, Italy, Austria, Canada
The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery NCT06230198 · ClinicalTrials.gov ↗ · Red Blood Cell Transfusion	Not applicable	Recruiting	2024-12	Canada
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial NCT04284839 · ClinicalTrials.gov ↗ · Bleeding Post Cardiac Surgery, Indication for Anticoagulation Drugs: Apixaban, Dabigatran, DOAC	Phase 3	Recruiting	2021-07	Germany, Canada, Australia
Higher vs. Lower Dose Heparin for PCI NCT04049591 · ClinicalTrials.gov ↗ · Cardiovascular Diseases, Percutaneous Coronary Intervention	Not applicable	Recruiting	2022-03	Canada
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial NCT05841056 · ClinicalTrials.gov ↗ · Atrial Fibrillation New Onset Drug: Amiodarone Hydrochloride	Phase 3	Recruiting	2024-06	Canada
Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients NCT05738252 · ClinicalTrials.gov ↗ · Gynecologic Cancer, Frailty, Oncology	Observational	Recruiting	2023-06	Canada
DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery NCT06519747 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Atrial Flutter	Observational	Recruiting	2024-10	Canada
Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial NCT05531474 · ClinicalTrials.gov ↗ · Cardiovascular Complication, Bariatric Surgery Candidate	Not applicable	Recruiting	2020-11	Canada
VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization NCT05724433 · ClinicalTrials.gov ↗ · Heart Failure	Not applicable	Recruiting	2023-01	Canada
Head of Bed After Ischemic Stroke Thrombectomy (HoBIT) NCT07367633 · ClinicalTrials.gov ↗ · Large Vessel Occlusion, Stroke, Ischemic Stroke	Not applicable	Recruiting	2026-09	Canada
Surgical Ablation of AF Efficacy Trial NCT05434819 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Heart Failure	Not applicable	Recruiting	2023-06	Canada
Post Discharge After Surgery Virtual Care with Remote Automated Monitoring Technology-2 (PVC-RAM-2) Trial NCT04876950 · ClinicalTrials.gov ↗ · Surgery, Perioperative Complication	Not applicable	Recruiting	2024-10	Canada
Stellate Ganglion Neuromodulation for the Treatment of Electrical Storm NCT07857889 · ClinicalTrials.gov ↗ · Ventricular Tachycardia (V-Tach) Storm	Not applicable	Not yet open	2027-01	Canada
Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium NCT03928236 · ClinicalTrials.gov ↗ · Delirium, Post-cardiac Surgery	Not applicable	Active, closed	2019-11	Canada
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease NCT05701358 · Acute Myocardial Infarction, Coronary Artery Disease	Not applicable	Active, closed	2023-06	Ireland, India, Germany, Spain, Italy, Netherlands, Sweden, Denmark, Poland, Austria, Norway, Canada, Australia
PeRiopEratiVE SmokiNg CessaTion Trial NCT05102123 · ClinicalTrials.gov ↗ · Smoking (Tobacco) Addiction, Smoking Cessation Drug: Cytisine	Phase 3	Active, closed	2024-01	Canada
Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology-3 Trial NCT05171569 · ClinicalTrials.gov ↗ · Surgery	Not applicable	Active, closed	2021-12	Canada
Living Green and Healthy for Teens NCT03996109 · ClinicalTrials.gov ↗ · Healthy Lifestyle, Adolescent Behavior	Not applicable	Active, closed	2021-12	Canada

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Population Health Research Institute trials

18 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Apixaban2 Dabigatran2 Edoxaban2 Rivaroxaban2 Warfarin2 Amiodarone Hydrochloride1 Colchicine1 Cytisine1 DOAC1 Herceptin1 Herzuma1 NOAC1 Non-Vitamin K Anticoagulant1 Ogivri1 Perjeta1 Pertuzumab1 Trastuzumab1 Trastuzumab emtansine1

Conditions in Population Health Research Institute trials

42 conditions

Atrial Fibrillation4 Heart Failure3 Cardiovascular Diseases2 Stroke2Atrial Flutter2Surgery2 Acute Myocardial Infarction1 Coronary Artery Disease1Hip Fractures1Myocardial Injury1Risk Factor, Cardiovascular1Health Behavior1Environmental Exposure1Bleeding Post-mechanical Valve Replacement1Thromboembolism Post-mechanical Valve Replacement1Peripheral Arterial Disease1Atherosclerosis of Extremities1Inflammation1Bleeding Post Cardiac Surgery1Indication for Anticoagulation1Calcium Release Deficiency Syndrome (CRDS)1Calcium Release Deficiency Syndrome1Cardiac Events1Delirium1

By trial register

Register	Trials	Recruiting
Clinical trials in Canada	26	20
Clinical trials in Australia	6	5
Clinical trials in Brazil	6	6
Clinical trials in Germany	5	4
Clinical trials in Spain	5	4
Clinical trials in Italy	5	4
Clinical trials in Netherlands	5	4
Clinical trials in Denmark	5	4
Clinical trials in Belgium	5	5
Clinical trials in India	4	3
Clinical trials in Sweden	3	2
Clinical trials in Poland	3	2
Clinical trials in Austria	2	1
Clinical trials in China	2	2
Clinical trials in Switzerland	2	2
Clinical trials in South Korea	2	2
Clinical trials in France	2	2
Clinical trials in Israel	2	2
Clinical trials in Ireland	1	0
Clinical trials in Norway	1	0
Clinical trials in Mexico	1	1
Clinical trials in Turkey	1	1

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Atrial Fibrillation

Sponsor	Trials
Yonsei University	12
Ottawa Heart Institute Research Corporation	8
Biosense Webster	7
Boston Scientific Corporation	6
Volta Medical	5
China National Center for Cardiovascular Diseases	5
Medtronic Cardiac Ablation Solutions	4
Karolinska Institutet	4
Insel Gruppe AG, University Hospital Bern	4
Universitätsklinikum Hamburg-Eppendorf	3

Sponsors with the most current trials registered for this condition.

Questions about Population Health Research Institute trials

How many clinical trials does Population Health Research Institute sponsor?

Population Health Research Institute is the lead sponsor of 26 current trials on ClinicalTrials.gov in our Canada, Australia, Brazil, Germany, Spain, Italy, Netherlands, Denmark, Belgium, India, Sweden, Poland, Austria, China, Switzerland, South Korea, France, Israel, Ireland, Norway, Mexico and Turkey registers, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.

Are Population Health Research Institute trials recruiting?

Yes. 20 of its 26 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Population Health Research Institute testing?

Its current trials name 18 drugs and biologicals as interventions. The most frequent are Apixaban (2), Dabigatran (2), Edoxaban (2), Rivaroxaban (2) and Warfarin (2). The number in brackets is how many of its trials name each drug.

Does Population Health Research Institute have clinical trials in Ireland?

Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.